Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)

Camille Verry, Sandrine Dufort, Julie Villa, Marylaure Gavard, Carole Iriart, Sylvie Grand, Julie Charles, Benoit Chovelon, Jean-Luc Cracowski, Jean-Louis Quesada, Christophe Mendoza, Lucie Sancey, Audrey Lehmann, Florence Jover, Jean-Yves Giraud, François Lux, Yannick Crémillieux, Stephen McMahon, Petrus J Pauwels, Daniel CagneyRoss Berbeco, Ayal Aizer, Eric Deutsch, Markus Loeffler, Géraldine Le Duc, Olivier Tillement, Jacques Balosso

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)
6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)'. Together they form a unique fingerprint.

Medicine & Life Sciences